EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY 4.0

Clinical Evaluation of a Novel CRISPR-Cas12a-Based RID-MyC Assay for the Diagnosis of Fungal Endophthalmitis

Hanith Raj Deivarajan, Prabhakara Sethupathy R, Vignesh Elamurugan, Akshayaa Vs, Reega P, Dharani Chelliah, Hari Vignesh S, Elakkiya Nandhini Gr, Kanmani M, Dharsini Nandhakumar, Karvannan Sevugamurthi, Saravanan Vr und 10 weitere

Ophthalmology Retina · 2025

DOI: 10.1016/j.oret.2024.11.003 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Ophthalmology Retina, 2025. Verfasst von Hanith Raj Deivarajan und 21 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, Aravind Medical Research Foundation, Madurai, Tamil Nadu, India; Aravind Medical Research Foundation Regional Centre, Coi…. Hauptthemen laut MEDLINE: Eye Infections, Fungal, Endophthalmitis, CRISPR-Cas Systems, DNA, Fungal. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Velux Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: This study evaluated the RID-MyC (Rapid Identification of Mycoses using clustered regularly interspaced short palindromic repeats [CRISPR]) assay, a CRISPR/Cas12a-based diagnostic tool, for its efficacy in diagnosing fungal endophthalmitis (FE) compared with panfungal polymerase chain reaction (PCR) and culture methods. DESIGN: A comparative cross-sectional study assessing the performance of the RID-MyC assay against established diagnostic modalities for FE. SUBJECTS: The study included 133 intraocular samples from 117 patients with suspected microbial endophthalmitis. METHODS: The study compared the sensitivity, specificity, positive predictive value, and negative predictive value of the RID-MyC assay against panfungal PCR and culture. The limit of detection for Aspergillus flavus and Candida albicans was determined for both RID-MyC and panfungal PCR across 3 different media: nuclease-free water, aqueous humor, and vitreous humor. Discrepancy analysis was conducted for discordant results, incorporating clinical outcomes and responses to antifungal treatment. MAIN OUTCOME MEASURES: The study primarily assessed the sensitivity, specificity, positive predictive value, and negative predictive value for clinical samples. Time to diagnosis was also evaluated. RESULTS: The RID-MyC assay demonstrated a sensitivity of 88.24% (95% confidence interval [CI], 63.56%-98.54%) and specificity of 93.1% (95% CI, 86.86%-96.98%), with positive predictive value and negative predictive value of 65.22% (95% CI, 48.45%-78.91%) and 98.18% (95% CI, 93.62%-99.50%), respectively. Discrepancy analysis enhanced sensitivity to 90.48% (95% CI, 69.62%-98.83%) and specificity to 96.43% (95% CI, 91.11%-99.02%). The RID-MyC assay was 10- to 1000-fold more sensitive than panfungal PCR in detecting A. flavus and C. albicans in intraocular specimens. The time to diagnosis with the RID-MyC assay was consistently

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Eye Infections, FungalEndophthalmitisCRISPR-Cas SystemsDNA, FungalCandida albicansAspergillus flavusHumansCross-Sectional StudiesMaleFemaleMiddle AgedAqueous HumorPolymerase Chain ReactionPredictive Value of TestsAgedVitreous Body

Stichwörter der Autor:innen

CRISPRDiagnosisEndophthalmitisFungal infectionsMycoses

Substanzen

DNA, Fungal

Autor:innen und Institutionen

  • Department of Microbiology, Aravind Medical Research Foundation, Madurai, Tamil Nadu, India; Aravind Medical Research Foundation Regional Centre, Coimbatore, Tamil Nadu, India.
  • Department of Microbiology, Aravind Medical Research Foundation, Madurai, Tamil Nadu, India; Department of Retina & Vitreous Services, Aravind Eye Hospital, Madurai, Tamil Nadu, India.
  • Aravind Medical Research Foundation Regional Centre, Coimbatore, Tamil Nadu, India; Department of Microbiology, PSG College of Arts and Science, Coimbatore, Tamil Nadu, India.
  • Department of Microbiology, Aravind Medical Research Foundation, Madurai, Tamil Nadu, India.
  • Aravind Medical Research Foundation Regional Centre, Coimbatore, Tamil Nadu, India.
  • Department of Retina & Vitreous Services, Aravind Eye Hospital, Coimbatore, Tamil Nadu, India.

Förderung

  • Velux Foundation

Zitieren

APA

Deivarajan, H. R., R, P. S., Elamurugan, V., Vs, A., P, R., Chelliah, D., S, H. V., Nandhini Gr, E., M, K., Nandhakumar, D., Sevugamurthi, K., Vr, S., K, A., Shah, P. K., Rammohan, R., Nair, A., Shah, K., Jose, A., Pandian, J., …, & Narendran, S. (2025). Clinical Evaluation of a Novel CRISPR-Cas12a-Based RID-MyC Assay for the Diagnosis of Fungal Endophthalmitis. Ophthalmology Retina. https://doi.org/10.1016/j.oret.2024.11.003

Vancouver

Deivarajan HR, R PS, Elamurugan V, Vs A, P R, Chelliah D, et al. Clinical Evaluation of a Novel CRISPR-Cas12a-Based RID-MyC Assay for the Diagnosis of Fungal Endophthalmitis. Ophthalmology Retina. 2025. doi:10.1016/j.oret.2024.11.003

BibTeX
@article{Deivarajan2025,
  author = {Deivarajan, Hanith Raj and R, Prabhakara Sethupathy and Elamurugan, Vignesh and Vs, Akshayaa and P, Reega and Chelliah, Dharani and S, Hari Vignesh and Nandhini Gr, Elakkiya and M, Kanmani and Nandhakumar, Dharsini and Sevugamurthi, Karvannan and Vr, Saravanan and K, Anuradha and Shah, Parag K and Rammohan, Ram and Nair, Abhishek and Shah, Krutin and Jose, Anju and Pandian, Jaishree and Prajna, Lalitha and Prajna, Venkatesh N and Narendran, Siddharth},
  title = {Clinical Evaluation of a Novel CRISPR-Cas12a-Based RID-MyC Assay for the Diagnosis of Fungal Endophthalmitis},
  journal = {Ophthalmology Retina},
  year = {2025},
  doi = {10.1016/j.oret.2024.11.003}
}
Kostenlos starten →